sellWeak cluster of 2
CRONIN JANE M. sold $2.1M of SHW
SVP - Enterprise Finance at SHERWIN WILLIAMS CO. 5,161 shares at an average of $398.06, traded Nov 25, 2024, filed Nov 27, 2024.
Warning score
38Value
$2.1M
5,161 shares
Holdings after
16,816
-23% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000089800-24-000166, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | MOption exercise Common Stock | +1,461 | $140.10 | $205k | 18,277 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Common Stock | +3,700 | $136.85 | $506k | 21,977 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stock | -5,161 | $398.06 | $2.1M | 16,816 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Common Stock | +338 | $295.83 | $100k | 17,154 | Nov 27, 2024 |
| Nov 25, 2024 | FTax withholding Common Stock | -251 | $397.93 | $100k | 16,903 | Nov 27, 2024 |
| Nov 25, 2024 | GGift Common Stock | -543 | $0.00 | $0 | 16,360 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Employee Stock Option (Right to Buy)derivative | -1,461 | $0.00 | $0 | 0 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Employee Stock Option (Right to Buy)derivative | -3,700 | $0.00 | $0 | 0 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Employee Stock Option (Right to Buy)derivative | -338 | $0.00 | $0 | 2,562 | Nov 27, 2024 |
Related signals
Other insiders at SHERWIN WILLIAMS CO and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 43Moderate | sell 2 | SHW SHERWIN WILLIAMS CO | GARCEAU MARY L SVP - CLO and Secretary | $6.3M | 15,770 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.